Care map information Quick info:
Scope:
• screening for type 2 diabetes in primary health care
• diagnosis of type 2 diabetes in primary health care
• diagnosis of impaired glucose tolerance (IGT) and impaired fasting glucose (IGF)
• management of impaired glucose tolerance (IGT) and impaired fasting glucose (IGF)
• non insulin managemement of type 2 diabetes in primary health care
• screening for complications of type 2 diabetes in primary health care
• management of complications of type 2 diabetes in primary health care
• referral criteria to secondary care for type 2 diabetes
• insulin management of type 2 diabetes Out of scope:
• management of gestational diabetes
• diagnosis and mangement in children
Updates to this pathway This care map has been drafted using the Map of Medicine editorial methodology (URL) and represents best clinical practice according to the highest quality evidence available, including the following guidelines:
• Royal Australian College of General Practitioners (RACGP): General practice management of type 2 diabetes 2 Resources for patients, families and carers
Quick info:
Information for patients from Diabetes Australia Vic Healthy Eatting Physical activity Blood glucose monitoring
National Diabetes Services Scheme (NDSS)
Diabetes Australia administers the National Diabetes Services Scheme in conjunction with state and territory diabetes organisations as Agents. The NDSS is an Australian Government initiative that provides subsidies on diabetes self-management products and support services. Through the NDSS, people with diabetes can receive telephone support through the National Infoline 1300 136 588, along with a range of diabetes information and education resources targeted for type 1 diabetes, type 2 diabetes and gestational diabetes.
• cardiovascular disease (CVD)
• renal disease
• diabetic retinopathy
• diabetic foot disease
• other neuropathic complications Regular monitoring and prompt treatment of problems reduces morbidity and mortality:
• ensure people with diabetes receive an annual assessment for the risk and presence of the complications of diabetes
• prevent microvascular complications through:
• biannual eye exams
• foot risk assessment and foot care counseling • for patients with impaired glucose regulation, aim to prevent progression of diabetes and CVD [1] • progressive narrowing and hardening of the coronary, cerebral, or peripheral arteries (atherosclerosis) leads to clinical events, such as [2] :
• acute myocardial infarction (MI)
• congestive cardiac failure
• sudden cardiac death
• stroke
• regular (usually at least annually) assessment and interventions reduce risk of developing CVD [1] :
• measure the full blood lipid profile when assessing cardiovascular risk at diagnosis and at least annually thereafter Renal disease in patients with diabetes:
• kidney damage and impairment of kidney function is due to long standing effects of diabetes on glomerulus [1] • severe diabetic nephropathy may result in kidney failure and end-stage renal disease [1] • assess for kidney damage at diagnosis and annually thereafter
• primary prevention of kidney damage from diabetes [2] :
• prevention of microvascular damage − diabetic nephropathy
• prevention of arterial damage − renovascular
• microalbuminuria is the earliest indicator of renal disease due to diabetes
• raised urine albumin levels and/or raised serum creatinine in diabetes increases risk of premature cardiovascular events [2] Published RACGP diabetic retinopathy screening recommendations [1] Ensure that all people with diabetes have a dilated fundus examination and visual acuity assessment at the diagnosis of diabetes and at least every 2 years [1] .
Examine higher risk patients (longer duration of diabetes, poor glycaemic control, BP or blood lipid control) without diabetic retinopathy at least annually [1] .
Conduct annual screening for Aboriginal or Torres Strait Islander peoples with diabetes [1]

Diabetic retinopathy
• small blood vessels in the body may become damaged in people with diabetes [2] • damage to blood vessels in the retina may lead to bleeding or scarring in the retina centre (macula):
• causing impaired vision [2] • in severe cases, diabetic retinopathy can cause blindness [3] • emergency review by ophthalmologist is required for [4] :
• sudden loss of vision Offloading of the wound can be achieved with the use of a total contact cast or other device rendered irremovable. People with diabetes-related foot ulceration are best managed by a multidisciplinary foot care team.
Diabetic foot disease [2]:
• foot problems are generally caused by peripheral vascular disease (progressive occlusion to arteries supplying extremities) or neuropathy (nerve damage) • problems include:
• poor circulation Diabetic peripheral neuropathy [1] ] All patients should be screened for distal symmetric polyneuropathy starting at diagnosis of type 2 diabetes and at least annually thereafter, using simple clinical tests. Antidepressants, including tricyclics, duloxetine and venlafaxine should be considered for the treatment of patients with painful diabetic peripheral neuropathy. Anticonvulsants, including pregabalin and gabapentin should be considered for the treatment of patients with painful diabetic peripheral neuropathy.
Charcot neuroarthropathy
Be alert to the possibility of Charcot neuroarthropathy -hot, red, asymmetrically swollen foot 
RACGP recommendations
Kidney status in people with type 2 diabetes should be assessed by:
• annual screening for albuminuria (note that dipstick urine test is not adequate to identify albuminuria)
• annual estimation of the glomerular filtration rate (eGFR in mL/min/1. The appearance of peripheral neuropathy should prompt review and consideration of improved glycaemic control [1] . The pain of peripheral neuropathy can be difficult to manage, although there is evidence that several agents can improve symptom control and quality of life. Tricyclic medications should be used as a first-line treatment, although side effects are not uncommon [1] . Gabapentin provides pain relief of a high level in approximately one-third of people who take this medication for painful neuropathic pain. Side effects are common (66%) [1] . Pregabalin at daily oral doses of 300-600 mg provides high levels of benefit for a minority of patients experiencing neuropathic pain including painful diabetic neuropathy [1] . Motor neuropathy sometimes occurs with muscle wasting, weakness and abnormalities of gait. This can contribute to foot problems by altering the biomechanics of the ankle and foot [1] . 
RACGP recommendations:
Reducing the risk or slowing the progression of nephropathy can be achieved by:
• optimising glucose control aiming for a general HbA1c target of 7% ( 53mmol/mol)
• optimising BP control
In people with type 2 diabetes and microalbuminuria or macroalbuminuria, ARB or ACEI antihypertensive should be used to protect against progression of kidney disease.
People with type 2 diabetes should be informed that smoking increases the risk of CKD.
People with diabetes and microalbuminuria are considered at high cardiovascular risk, and should be treated with multifactorial interventions. • an area on their foot that is swollen, discoloured or discharging
References
• a wound that is not healing
• a foot problem such as an ulcer or an infection that has required hospital admission within the last three months 
REFERRAL Nephrologists
Quick info:
Referral criteria for nephrologist may include [1] :
• glomerular haematuria with macroalbuminuria
• eGFR <30 mL/min/1.73m2
• persistent significant albuminuria (UACR ≥30 mg/mmol)
• consistent decline in eGFR from a baseline of <60 mL/min/1.73m2 (a decline >5 mL/min/1.73m2 over a 6-month period which is confirmed on at least three separate readings) • CKD and hypertension that is hard to get to target despite at least three antihypertensive agents.
Peninsula Health Frankston Hospital Renal unit
Ph: (03) 9784 7243 Fax: (03) 9784 7289 The Department of Nephrology provides inpatient care, acute dialysis and consultation for all patients admitted to Frankston Hospital with kidney problems. In addition, the department provides a range of outpatient clinics for chronic kidney disease, haemodialysis, peritoneal dialysis and transplant patients. 
Private nephrologists
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Disclaimers
It is not the function of the Pathways Program, Frankston-Mornington Peninsula Medicare Local to substitute for the role of the clinician, but to support the clinician in enabling access to know-how and knowledge. Users of the Map of Medicine are therefore urged to use their own professional judgement to ensure that the patient receives the best possible care. Whilst reasonable efforts have been made to ensure the accuracy of the information on this online clinical knowledge resource, we cannot guarantee its correctness and completeness. The information on the Map of Medicine is subject to change and we cannot guarantee that it is up-to-date
